Bacteriophage therapy: a viable alternative to antibiotics?

Samuel Nellany BSc (Hons), Medical student, University of Glasgow Published on 01/08/2026 Guide for Authors Submit your article BGTHA Journal Edition 17 Outline Abstract Introduction Bacteriophage structure The mechanism of bacteriophage therapy Specificity of phage therapy The potential to resensitise bacteria to antibiotics Phage-antibiotic synergy Safety of phage therapy Production issues Regulatory challenges Conclusion References…

New paper published: Comparative effectiveness of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in children over multiple influenza seasons (2019–2023)

Abstract Vaccine effectiveness (VE) of quadrivalent live attenuated influenza vaccine (LAIV4) and quadrivalent inactivated influenza vaccine (IIV4) in children in 13 European countries and the US during the 2019–2023 influenza seasons was evaluated from published literature, congress presentations, public health websites, and personal communications with investigators.A meta-analysis was performed by assessing LAIV4 and/or IIV4 VE…